Taligen Therapeutics has initiated a corporate growth plan with the appointment of Abbie Celniker as CEO and the establishment of its headquarters in Cambridge, Massachusetts. Dr Celniker succeeds Woodruff Emlen, a co-founder of the company who remains as president.
Medarex has received a milestone payment of an undisclosed amount from its licensing partner, Centocor R&D for the acceptance of an investigational new drug application to the FDA for an undisclosed antibody.
Bausch & Lomb, an eye health company, has named Alan Farnsworth as its new senior vice president of customer service and information technology and chief information officer. Mr Farnsworth remains a corporate vice president.
U-Systems, a provider of breast ultrasound systems, has appointed Ron Ho as its new president and CEO. Mr Ho succeeds Robert Thompson who served as interim president and CEO.
We are happy to announce that InternationalDrugMart.com has now become a valid member of Pharmacy Checker verification program to provide safe shopping...
Mumbai, March 31 Cipla is set to sell its generic version of Deferasirox, a once-a-day oral iron chelator used to treat iron overload that occurs due to blood transfusions...
Eli Lilly and Co. has lost a European court bid to stop a pharmacy from buying medications in Turkey at cheaper prices and selling them for more in the United States...
TMUMBAI (Thomson Financial) - India's Sun Pharmaceutical Industries Ltd said it received final approval from the US Food and Drug Administration for its abbreviated new drug application to market its generic version of Hoffman La Roche Ltd's Demadex Torsemide tablets....
BANGALORE, Feb. 6, 2008 (Thomson Financial delivered by Newstex) -- India's Ranbaxy Laboratories Ltd said its US unit has received US FDA approval to manufacture and market...
Ranbaxy Laboratories Ltd has received final approval from US Food and Drug Administration (FDA) to manufacture and market Cetirizine Hydrochloride Oral Solution (Allergy) and Children's...
Pharmaceutical firm Glenmark on Friday said that it has received ANDA approval for its anti-inflammatory and anti-diabetic drugs and will soon commence marketing...
